Bezuclastinib
Cogent Biosciences (COGT)
Decision dateDec 30, 2026
45 days away
Marketer take
A second indication decision weeks after GIST, which would let one brand team run two launches with very different audiences.
- Sponsor company
- Cogent Biosciences (COGT)
- Indication
- Nonadvanced systemic mastocytosis (NonAdvSM)
- Therapeutic area
- Hematology, Rare disease
- Event
- PDUFA target action date
- Date
- Dec 30, 2026
- Status
- Upcoming
- Source
- company press release
- Last verified
- Nov 15, 2026
Dates and status come from the linked public source as of the last verified date. Spot an error or have an update?